Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T16308 | Target Info | |||
Target Name | Rotamase Pin1 (PIN1) | ||||
Synonyms | Prolyl isomerase Pin1; Peptidyl-prolyl cis-trans isomerase Pin1; Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; Peptidyl prolyl cis/trans isomerase Pin1; PPIase Pin1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PIN1 | ||||
Biochemical Class | Cis-trans-isomerase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | M-phase inducer phosphatase 3 (MPIP3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Dual specificity phosphatase Cdc25C; Cdc25C phosphatase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Protein-peptide | [3] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Pyruvate kinase M2 (PKM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor M2-PK; Thyroid hormone-binding protein 1; THBP1; Pyruvate kinase PKM; Pyruvate kinase muscle isozyme; Pyruvate kinase isozymes M1/M2; Pyruvate kinase 2/3; PKM2; PK3; PK2; p58; Opa-interacting protein 3; OIP-3; OIP3; Cytosolic thyroid hormone-binding protein; CTHBP | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Biochemical Activity | [4] | |||
3 | Protein-peptide | [4] | |||
4 | Reconstituted Complex | [5] | |||
5 | Yeast two hybrid | [6] | |||
Interacting Target Name | Polo-like kinase 1 (PLK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STPK13; Serine-threonine protein kinase 13; Serine/threonine-protein kinase PLK1; Serine/threonine-protein kinase 13; PLK-1; Plk1; PLK; Mitoticserine-threonine kinase polo-like kinase 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Reconstituted Complex | [7] | |||
Microtubule-associated | [+] 1 Microtubule-associated | + | |||
Interacting Target Name | Microtubule-associated protein tau (MAPT) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | tau; TAU; Paired helical filament-tau; Paired helical filamenttau; Neurofibrillary tangle protein; MTBT1; Microtubule-associated protein tau; MAPTL | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Reconstituted Complex | [9] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [11] | |||
3 | Reconstituted Complex | [12] | |||
4 | Reconstituted Complex | [10] | |||
5 | Yeast two hybrid | [6] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Reconstituted Complex | [13] | |||
4 | Yeast two hybrid | [15] | |||
Interacting Target Name | Transcription factor AP-1 (JUN) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Transcription factor AP-1; Proto-oncogene c-jun; P39; C-jun proto-oncogene; AP-1 transcription factor; AP1; Activator protein-1; Activator protein 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Reconstituted Complex | [17] | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 2 (SMAD2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JV18; JV18.1; MADH2; MADR2; hMAD.2; hSMAD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Reconstituted Complex | [13] | |||
Other proteins | [+] 3 Other proteins | + | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Affinity Capture-Western | [19] | |||
3 | Affinity Capture-Western | [20] | |||
4 | Affinity Capture-Western | [21] | |||
5 | Reconstituted Complex | [19] | |||
Interacting Protein Name | Protein PRRC1 (PRRC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [5] | |||
2 | Yeast two hybrid | [22] | |||
Interacting Protein Name | Transcription elongation factor SPT5 (SUPT5H) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SPT5; SPT5H; Tat.CT1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Yeast two hybrid | [15] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998 Mar 1;12(5):706-20. | ||||
REF 2 | Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 1999 Feb 26;283(5406):1325-8. | ||||
REF 3 | The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol. 2001 Nov;21(22):7617-28. | ||||
REF 4 | ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012 Dec;14(12):1295-304. | ||||
REF 5 | WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol. 2005 Aug;25(16):7092-106. | ||||
REF 6 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. | ||||
REF 7 | Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem. 2005 Nov 4;280(44):36575-83. | ||||
REF 8 | Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem. 2006 Feb 17;281(7):4117-25. | ||||
REF 9 | The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 1999 Jun 24;399(6738):784-8. | ||||
REF 10 | The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 2002 Oct 24;419(6909):853-7. | ||||
REF 11 | Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem. 2002 Dec 13;277(50):47976-9. | ||||
REF 12 | The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol. 2007 Oct;14(10):912-20. | ||||
REF 13 | Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins. J Biol Chem. 2009 Mar 6;284(10):6109-15. | ||||
REF 14 | Pin1 promotes transforming growth factor-beta-induced migration and invasion. J Biol Chem. 2010 Jan 15;285(3):1754-64. | ||||
REF 15 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 16 | Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001 Jul 2;20(13):3459-72. | ||||
REF 17 | Multivalent Interactions with Fbw7 and Pin1 Facilitate Recognition of c-Jun by the SCFFbw7 Ubiquitin Ligase. Structure. 2018 Jan 2;26(1):28-39.e2. | ||||
REF 18 | Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol. 2008 Feb;28(3):997-1006. | ||||
REF 19 | Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1. J Biol Chem. 2010 Mar 26;285(13):9485-92. | ||||
REF 20 | Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover. J Biol Chem. 2011 Dec 30;286(52):44403-11. | ||||
REF 21 | Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog. 2014 Feb 27;10(2):e1003975. | ||||
REF 22 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 23 | The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J Mol Biol. 2001 Sep 28;312(4):675-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.